Dr Reddy’s Laboratories launches penicillamine capsules in US
It is a chelating agent used in the treatment of Wilson’s disease and to reduce cystine excretion in cystinuria and to treat…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Reddy’s Laboratories
Dr Reddy’s Laboratories launches AVIGAN (favipiravir) in India
Dr Reddy’s AVIGAN comes in a pack of 122 tablets with a two-year shelf life
Dr Reddy’s Laboratories launches generic Ciprodex Otic Suspension, USP in US
It is available as 7.5 mL fill in a 10 mL bottle
DRL receives US FDA’s approval for XEGLYZETM (abametapir) lotion
XEGLYZE is indicated for the topical treatment of head lice infestation in patients 6 months of age and older
Dr Reddy’s Laboratories launch OTC Nicotine Polacrilex Lozenges in the US
They are available in multiple pack sizes
NPPA fixes retail prices for 14 formulations
The fixed formulations are used to treat diabetes, hypertension, cholesterol, women’s health and mental health disorders
Expect to launch 25 products in US this fiscal: Dr Reddy’s
As of March 31, 2020, the company has 99 cumulative filings pending for approval with the US Food and Drug Administration (US…
Dr Reddy’s Laboratories launch Abiraterone Acetate Tablets USP in the US
The drug is used for the treatment of prostate cancer
Centre clarifies reasons for delay in approvals for remdesivir
Informs that it is awaiting data on some crucial parameters from companies that have applied for manufacturing and marketing…
Dr Reddy’s signs licensing agreement with Gilead Sciences for remdesivir
Dr Reddy’s will receive technology transfer from Gilead for manufacturing of this drug and needs to do the manufacturing scale-up…